Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme

Experimental Cell Research

Volumn 317, Issue 11, 2011, Pages 1513-1526

  Stockhausen, Marie Thérése ^a   Broholm, Helle ^b   Villingshøj, Mette ^a   Kirchhoff, Maria ^c   Gerdes, Tommy ^c   Kristoffersen, Karina ^a   Kosteljanetz, Michael ^b   Spang Thomsen, Mogens ^d   Poulsen, Hans Skovgaard ^a  

^a FINSEN LABORATORY   (Denmark)

^b Mental Health Services CPH   (Denmark)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

EGFR; EGFRvIII; Glioblastoma multiforme; Stem cells

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MOUSE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL; TUMOR XENOGRAFT; WESTERN BLOTTING;

MUS;

EID: 79956295188     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.04.001     Document Type: Article

References (58)

1. Kleihues P., Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro Oncol. 1999, 1:44-51.
2. Ohgaki H., Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am. J. Pathol. 2007, 170:1445-1453.
3. Watanabe K., Tachibana O., Sata K., Yonekawa Y., Kleihues P., Ohgaki H. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol. 1996, 6:217-223.
4. Ekstrand A.J., Longo N., Hamid M.L., Olson J.J., Liu L., Collins V.P., James C.D. Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene 1994, 9:2313-2320.
5. Nishikawa R., Ji X.D., Harmon R.C., Lazar C.S., Gill G.N., Cavenee W.K., Huang H.J. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc. Natl Acad. Sci. U. S. A. 1994, 91:7727-7731.
6. Huang H.S., Nagane M., Klingbeil C.K., Lin H., Nishikawa R., Ji X.D., Huang C.M., Gill G.N., Wiley H.S., Cavenee W.K. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J. Biol. Chem. 1997, 272:2927-2935.
7. Damstrup L., Wandahl P.M., Bastholm L., Elling F., Skovgaard P.H. Epidermal growth factor receptor mutation type III transfected into a small cell lung cancer cell line is predominantly localized at the cell surface and enhances the malignant phenotype. Int. J. Cancer 2002, 97:7-14.
8. Pedersen M.W., Tkach V., Pedersen N., Berezin V., Poulsen H.S. Expression of a naturally occurring constitutively active variant of the epidermal growth factor receptor in mouse fibroblasts increases motility. Int. J. Cancer 2004, 108:643-653.
9. Learn C.A., Hartzell T.L., Wikstrand C.J., Archer G.E., Rich J.N., Friedman A.H., Friedman H.S., Bigner D.D., Sampson J.H. Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme. Clin. Cancer Res. 2004, 10:3216-3224.
10. Pedersen M.W., Pedersen N., Ottesen L.H., Poulsen H.S. Differential response to gefitinib of cells expressing normal EGFR and the mutant EGFRvIII. Br. J. Cancer 2005, 93:915-923.
11. Boockvar J.A., Kapitonov D., Kapoor G., Schouten J., Counelis G.J., Bogler O., Snyder E.Y., McIntosh T.K., O'Rourke D.M. Constitutive EGFR signaling confers a motile phenotype to neural stem cells. Mol. Cell. Neurosci. 2003, 24:1116-1130.
12. Li B., Yuan M., Kim I.A., Chang C.M., Bernhard E.J., Shu H.K. Mutant epidermal growth factor receptor displays increased signaling through the phosphatidylinositol-3 kinase/AKT pathway and promotes radioresistance in cells of astrocytic origin. Oncogene 2004, 23:4594-4602.
13. Luwor R.B., Zhu H.J., Walker F., Vitali A.A., Perera R.M., Burgess A.W., Scott A.M., Johns T.G. The tumor-specific de2-7 epidermal growth factor receptor (EGFR) promotes cells survival and heterodimerizes with the wild-type EGFR. Oncogene 2004, 23:6095-6104.
14. Marshall J. Clinical implications of the mechanism of epidermal growth factor receptor inhibitors. Cancer 2006, 107:1207-1218.
15. Layfield L.J., Willmore C., Tripp S., Jones C., Jensen R.L. Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme: prognostic significance and relationship to other prognostic factors. Appl. Immunohistochem. Mol. Morphol. 2006, 14:91-96.
16. Liu L., Backlund L.M., Nilsson B.R., Grander D., Ichimura K., Goike H.M., Collins V.P. Clinical significance of EGFR amplification and the aberrant EGFRvIII transcript in conventionally treated astrocytic gliomas. J. Mol. Med. 2005, 83:917-926.
17. Heimberger A.B., Suki D., Yang D., Shi W., Aldape K. The natural history of EGFR and EGFRvIII in glioblastoma patients. J. Transl. Med. 2005, 3:38.
18. Heimberger A.B., Hlatky R., Suki D., Yang D., Weinberg J., Gilbert M., Sawaya R., Aldape K. Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients. Clin. Cancer Res. 2005, 11:1462-1466.
19. Houillier C., Lejeune J., Benouaich-Amiel A., Laigle-Donadey F., Criniere E., Mokhtari K., Thillet J., Delattre J.Y., Hoang-Xuan K., Sanson M. Prognostic impact of molecular markers in a series of 220 primary glioblastomas. Cancer 2006, 106:2218-2223.
20. Quan A.L., Barnett G.H., Lee S.Y., Vogelbaum M.A., Toms S.A., Staugaitis S.M., Prayson R.A., Peereboom D.M., Stevens G.H., Cohen B.H., Suh J.H. Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys. 2005, 63:695-703.
21. Shinojima N., Tada K., Shiraishi S., Kamiryo T., Kochi M., Nakamura H., Makino K., Saya H., Hirano H., Kuratsu J., Oka K., Ishimaru Y., Ushio Y. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. Cancer Res. 2003, 63:6962-6970.
22. Aldape K.D., Ballman K., Furth A., Buckner J.C., Giannini C., Burger P.C., Scheithauer B.W., Jenkins R.B., James C.D. Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance. J. Neuropathol. Exp. Neurol. 2004, 63:700-707.
23. Lassman A.B., Rossi M.R., Raizer J.J., Abrey L.E., Lieberman F.S., Grefe C.N., Lamborn K., Pao W., Shih A.H., Kuhn J.G., Wilson R., Nowak N.J., Cowell J.K., DeAngelis L.M., Wen P., Gilbert M.R., Chang S., Yung W.A., Prados M., Holland E.C. Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01. Clin. Cancer Res. 2005, 11:7841-7850.
24. Mellinghoff I.K., Wang M.Y., Vivanco I., Haas-Kogan D.A., Zhu S., Dia E.Q., Lu K.V., Yoshimoto K., Huang J.H., Chute D.J., Riggs B.L., Horvath S., Liau L.M., Cavenee W.K., Rao P.N., Beroukhim R., Peck T.C., Lee J.C., Sellers W.R., Stokoe D., Prados M., Cloughesy T.F., Sawyers C.L., Mischel P.S. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N. Engl. J. Med. 2005, 353:2012-2024.
25. Rich J.N., Reardon D.A., Peery T., Dowell J.M., Quinn J.A., Penne K.L., Wikstrand C.J., Van Duyn L.B., Dancey J.E., McLendon R.E., Kao J.C., Stenzel T.T., Ahmed Rasheed B.K., Tourt-Uhlig S.E., Herndon J.E., Vredenburgh J.J., Sampson J.H., Friedman A.H., Bigner D.D., Friedman H.S. Phase II trial of gefitinib in recurrent glioblastoma. J. Clin. Oncol. 2004, 22:133-142.
26. Bigner S.H., Humphrey P.A., Wong A.J., Vogelstein B., Mark J., Friedman H.S., Bigner D.D. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res. 1990, 50:8017-8022.
27. Pandita A., Aldape K.D., Zadeh G., Guha A., James C.D. Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR. Genes Chromosomes Cancer 2004, 39:29-36.
28. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., Fiocco R., Foroni C., Dimeco F., Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004, 64:7011-7021.
29. Ignatova T.N., Kukekov V.G., Laywell E.D., Suslov O.N., Vrionis F.D., Steindler D.A. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002, 39:193-206.
30. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63:5821-5828.
31. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
32. Yuan X., Curtin J., Xiong Y., Liu G., Waschsmann-Hogiu S., Farkas D.L., Black K.L., Yu J.S. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 2004, 23:9392-9400.
33. Lee J., Kotliarova S., Kotliarov Y., Li A., Su Q., Donin N.M., Pastorino S., Purow B.W., Christopher N., Zhang W., Park J.K., Fine H.A. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006, 9:391-403.
34. Rygaard K., Spang-Thomsen M. Quantitation and gompertzian analysis of tumor growth. Breast Cancer Res. Treat. 1997, 46:303-312.
35. Gerdes T., Kirchhoff M., Bryndorf T. Automatic analysis of multiplex ligation-dependent probe amplification products (exemplified by a commercial kit for prenatal aneuploidy detection). Electrophoresis 2005, 26:4327-4332.
36. Ekstrand A.J., James C.D., Cavenee W.K., Seliger B., Pettersson R.F., Collins V.P. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res. 1991, 51:2164-2172.
37. Eller J.L., Longo S.L., Hicklin D.J., Canute G.W. Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme. Neurosurgery 2002, 51:1005-1013.
38. Marquez A., Wu R., Zhao J., Tao J., Shi Z. Evaluation of epidermal growth factor receptor (EGFR) by chromogenic in situ hybridization (CISH) and immunohistochemistry (IHC) in archival gliomas using bright-field microscopy. Diagn. Mol. Pathol. 2004, 13:1-8.
39. Moroni M., Veronese S., Benvenuti S., Marrapese G., Sartore-Bianchi A., Di Nicolantonio F., Gambacorta M., Siena S., Bardelli A. Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study. Lancet Oncol. 2005, 6:279-286.
40. Wong A.J., Bigner S.H., Bigner D.D., Kinzler K.W., Hamilton S.R., Vogelstein B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc. Natl Acad. Sci. U. S. A. 1987, 84:6899-6903.
41. Gunther H.S., Schmidt N.O., Phillips H.S., Kemming D., Kharbanda S., Soriano R., Modrusan Z., Meissner H., Westphal M., Lamszus K. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 2008, 27:2897-2909.
42. Doetsch F., Caille I., Lim D.A., Garcia-Verdugo J.M., varez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999, 97:703-716.
43. Nishikawa R., Sugiyama T., Narita Y., Furnari F., Cavenee W.K., Matsutani M. Immunohistochemical analysis of the mutant epidermal growth factor, deltaEGFR, in glioblastoma. Brain Tumor Pathol. 2004, 21:53-56.
44. Humphrey P.A., Wong A.J., Vogelstein B., Friedman H.S., Werner M.H., Bigner D.D., Bigner S.H. Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. Cancer Res. 1988, 48:2231-2238.
45. Schlegel J., Stumm G., Brandle K., Merdes A., Mechtersheimer G., Hynes N.E., Kiessling M. Amplification and differential expression of members of the erbB-gene family in human glioblastoma. J. Neurooncol. 1994, 22:201-207.
46. Fenstermaker R.A., Ciesielski M.J. Deletion and tandem duplication of exons 2-7 in the epidermal growth factor receptor gene of a human malignant glioma. Oncogene 2000, 19:4542-4548.
47. Moscatello D.K., Holgado-Madruga M., Emlet D.R., Montgomery R.B., Wong A.J. Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor. J. Biol. Chem. 1998, 273:200-206.
48. Frederick L., Wang X.Y., Eley G., James C.D. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res. 2000, 60:1383-1387.
49. Goike H.M., Asplund A.C., Pettersson E.H., Liu L., Sanoudou D., Collins V.P. Acquired rearrangement of an amplified epidermal growth factor receptor (EGFR) gene in a human glioblastoma xenograft. J. Neuropathol. Exp. Neurol. 1999, 58:697-701.
50. Ciesielski M.J., Fenstermaker R.A. Oncogenic epidermal growth factor receptor mutants with tandem duplication: gene structure and effects on receptor function. Oncogene 2000, 19:810-820.
51. Fenstermaker R.A., Ciesielski M.J., Castiglia G.J. Tandem duplication of the epidermal growth factor receptor tyrosine kinase and calcium internalization domains in A-172 glioma cells. Oncogene 1998, 16:3435-3443.
52. Filmus J., Pollak M.N., Cairncross J.G., Buick R.N. Amplified, overexpressed and rearranged epidermal growth factor receptor gene in a human astrocytoma cell line. Biochem. Biophys. Res. Commun. 1985, 131:207-215.
53. Thomas C., Ely G., James C.D., Jenkins R., Kastan M., Jedlicka A., Burger P., Wharen R. Glioblastoma-related gene mutations and over-expression of functional epidermal growth factor receptors in SKMG-3 glioma cells. Acta Neuropathol. (Berl.) 2001, 101:605-615.
54. Gage F.H., Ray J., Fisher L.J. Isolation, characterization, and use of stem cells from the CNS. Annu. Rev. Neurosci. 1995, 18:159-192.
55. McKay R. Stem cells in the central nervous system. Science 1997, 276:66-71.
56. Weickert C.S., Webster M.J., Colvin S.M., Herman M.M., Hyde T.M., Weinberger D.R., Kleinman J.E. Localization of epidermal growth factor receptors and putative neuroblasts in human subependymal zone. J. Comp. Neurol. 2000, 423:359-372.
57. Holland E.C., Hively W.P., Depinho R.A., Varmus H.E. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev. 1998, 12:3675-3685.
58. Ayuso-Sacido A., Moliterno J.A., Kratovac S., Kapoor G.S., O'Rourke D.M., Holland E.C., Garcia-Verdugo J.M., Roy N.S., Boockvar J.A. Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells. J. Neurooncol. 2010, 97:323-337.